NasdaqCM - Delayed Quote USD
FibroBiologics, Inc. (FBLG)
0.8498
+0.0613
+(7.77%)
At close: June 4 at 4:00:01 PM EDT
0.8900
+0.04
+(4.73%)
After hours: June 4 at 7:37:55 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Peter O'Heeron | Founder, Chairperson & CEO | 1.02M | -- | 1964 |
| Dr. Hamid Khoja Ph.D. | Chief Scientific Officer | 511.75k | -- | 1970 |
| Mr. Ruben A. Garcia J.D. | General Counsel | 469.57k | -- | 1978 |
FibroBiologics, Inc.
455 East Medical Center Boulevard
Suite 300
Houston, TX 77598
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 13
Description
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.
Corporate Governance
FibroBiologics, Inc.’s ISS Governance QualityScore as of June 1, 2025 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 10; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 14, 2025 at 8:00 PM UTC
FibroBiologics, Inc. Earnings Date
Recent Events
February 6, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
January 17, 2025 at 12:00 AM UTC
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Related Tickers
CNTX Context Therapeutics Inc.
0.5753
-1.15%
RANI Rani Therapeutics Holdings, Inc.
0.5599
+0.97%
BCDA BioCardia, Inc.
2.1700
-0.91%
CLDI Calidi Biotherapeutics, Inc.
0.3647
+2.19%
CNTB Connect Biopharma Holdings Limited
0.7714
-4.88%
JUNS Jupiter Neurosciences, Inc.
0.8150
-1.51%
CLSD Clearside Biomedical, Inc.
0.7600
+3.40%
ABP Abpro Holdings, Inc.
0.2112
-1.31%
SXTP 60 Degrees Pharmaceuticals, Inc.
2.8600
-1.72%
OVID Ovid Therapeutics Inc.
0.3096
+3.65%